Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Pandora and others
View:
Post by bealert on May 10, 2023 6:16pm

Pandora and others

Last four trading days:  708 shares, 48161, 14165 and 6171

This is all exchanges but still doesn't amount to a hill of beans since the latest P.Release.

SBM and their lame, overpaid promoters can't seem  to capitalize on anything.  This is the problem!  We can't sustain any momentum because nobody wants to trust the powers to be any longer after them having a lengthy track record of lack of transparancy and business acumen, and in particular a sense of urgency to capture the moment.

No amount of time will fix this problem as the people involved seem uncoachable and unresponsive and simply don't know how to care about the damage they so ignorantly inflict. Only a change of executives or just a fluke of luck will bring results now.

I think it's a big joke about Dr Bieber on board.  Not a single word for months since he was going to 'reinvent' Sirona.  I surely hope he is not getting paid anything.

I'm simply sick of this lot and find it extremely frustrating to come to terms with their incompetence.

BeAlert
Comment by Pandora on May 11, 2023 9:41am
457K traded out of the gate on the Venture. Certainly a far better scene than 500 each day. Price went down a penny but it's early yet.
Comment by navajojoe on May 11, 2023 10:52am
This post has been removed in accordance with Community Policy
Comment by forhandlaren on May 11, 2023 10:57am
I can sense disappointment in the air, hence the sell-off. The indication of another clinical trial might delay a deal, but I'm not so sure that a delay would be very long. The basics are already covered. Groundbreaking clinical results that can be evaluated now. Interest raised among potential partners. The comference presentation is underway. New results would be the icing on the cake ...more  
Comment by BradlTheGerman on May 11, 2023 11:28am
Looks like day traders are taking profits out. Fundamental nothing has changed. Great times and profits are ahead. Patience is the word. Buy if all others are selling. I am following myself this stock market rule. The reward will come. I am always right for 95 percent 
Comment by navajojoe on May 11, 2023 12:12pm
This post has been removed in accordance with Community Policy
Comment by biorun on May 11, 2023 1:03pm
Yes, looks like there is some interest in buying at these levels as well. I am not fussed today. 
Comment by BradlTheGerman on May 11, 2023 11:34am
"The indication of another clinical" is the reason for the sell off. Quick money maker are taking out their money.  Nothing has changed!! I am buying the dip, willing to hold the stock at least for 5 years. Patience is the answer 
Comment by MirrorWorldMan on May 11, 2023 2:21pm
More accurately, it's the cost of doing another clinical trial in other areas of skin (neck etc) before securing a partner and receiving cash flow for more research over more time. Also, as we have see,  study results mean little when Howie squanders their value by poor monetary deals that are announced over significant delays. More Study=More Dilution without an income source. True ...more  
Comment by PeterG on May 11, 2023 2:46pm
Not true as Sirona said that the Allergan Deal for TFC-1067 makes Sirona a profitable company. So I can't believe that we are going to see a non diluted financing again. Just my view.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities